The role of fatty acid β-oxidation in lymphangiogenesis

Nature

Volumn 542, Issue 7639, 2017, Pages 49-54

  Wong, Brian W ^a,b   Wang, Xingwu ^a,b   Zecchin, Annalisa ^a,b   Thienpont, Bernard ^b,c   Cornelissen, Ivo ^a,b   Kalucka, Joanna ^a,b   García Caballero, Melissa ^d   Missiaen, Rindert ^a,b   Huang, Hongling ^a,b   Brüning, Ulrike ^a,b   Blacher, Silvia ^d   Vinckier, Stefan ^a,b   Goveia, Jermaine ^a,b   Knobloch, Marlen ^e   Zhao, Hui ^b,c   Dierkes, Cathrin ^f   Shi, Chenyan ^a,b   Hägerling, René ^f   Moral Dardé, Veronica ^a,b   Wyns, Sabine ^a,b   Lippens, Martin ^a,b   Jessberger, Sebastian ^e   Fendt, Sarah Maria ^a,b   Luttun, Aernout ^g   Noel, Agnès ^d   Kiefer, Friedemann ^f   Ghesquière, Bart ^b   Moons, Lieve ^h   Schoonjans, Luc ^a,b   Dewerchin, Mieke ^a,b   Eelen, Guy ^a,b   Lambrechts, Diether ^b,c   Carmeliet, Peter ^a,b   more..

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c KU Leuven and University Hospitals Leuven and Leuven Cancer Institute   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; CARNITINE PALMITOYLTRANSFERASE 1A; CARNITINE PALMITOYLTRANSFERASE I; CRE RECOMBINASE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3; ACETIC ACID DERIVATIVE; CARNITINE PALMITOYLTRANSFERASE; CPT1B PROTEIN, MOUSE; FATTY ACID; HISTONE; HOMEODOMAIN PROTEIN; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; FATTY ACID; GENE EXPRESSION; GENETIC MARKER; INHIBITION; LABORATORY METHOD; METABOLISM; OXIDATION; PROTEIN; RODENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CITRIC ACID CYCLE; CONTROLLED STUDY; CYTOSOL; EMBRYO; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FEMALE; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHANGIOGENESIS; LYMPHATIC ENDOTHELIAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ACETYLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; LYMPH VESSEL; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN SYNTHESIS; UMBILICAL ARTERY;

MUS MUSCULUS;

ACETATES; ACETYL COENZYME A; ACETYLATION; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; FATTY ACIDS; FEMALE; HISTONES; HOMEODOMAIN PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; PROTEIN BIOSYNTHESIS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS; UMBILICAL ARTERIES; UP-REGULATION;

EID: 85016143129     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature21028     Document Type: Article

References (47)

1. Christiansen, A. & Detmar, M. Lymphangiogenesis and cancer. Genes Cancer 2, 1146-1158 (2011).
2. Kim, H., Kataru, R. P. & Koh, G. Y. Regulation and implications of inflammatory lymphangiogenesis. Trends Immunol. 33, 350-356 (2012).
3. Alitalo, K. The lymphatic vasculature in disease. Nat. Med. 17, 1371-1380 (2011).
4. Ghesquiere, B., et al. Metabolism of stromal and immune cells in health and disease. Nature 511, 167-176 (2014).
5. Petrova, T. V. et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21, 4593-4599 (2002).
6. Wigle, J. T. et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21, 1505-1513 (2002).
7. Yang, Y. & Oliver, G. Development of the mammalian lymphatic vasculature. J. Clin. Invest. 124, 888-897 (2014).
8. Aranguren, X. L. et al. COUP-TFII orchestrates venous and lymphatic endothelial identity by homo-or hetero-dimerisation with PROX1. J. Cell Sci. 126, 1164-1175 (2013).
9. Srinivasan, R. S. et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 21, 2422-2432 (2007).
10. Srinivasan, R. S. et al. The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev. 28, 2175-2187 (2014).
11. Schoors, S. et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520, 192-197 (2015).
12. Karkkainen, M. J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5, 74-80 (2004).
13. Hagerling, R. et al. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J. 32, 629-644 (2013).
14. Bazigou, E. et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J. Clin. Invest. 121, 2984-2992 (2011).
15. Lin, F. J. et al. Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J. Clin. Invest. 120, 1694-1707 (2010).
16. Hirashima, M. et al. Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos. Dev. Biol. 316, 149-159 (2008).
17. Mouta-Bellum, C. et al. Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85a , p55a , and p50a . Dev. Dyn. 238, 2670-2679 (2009).
18. Stanczuk, L. et al. cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels. Cell Rep. S2211-1247(15)00172-2 (2015).
19. Hong, Y. K. et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225, 351-357 (2002).
20. Johnson, N. C. et al. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 22, 3282-3291 (2008).
21. Ichise, T., Yoshida, N. & Ichise, H. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells. PLoS One 7, e51639 (2012).
22. Goldman, J. et al. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J. 21, 1003-1012 (2007).
23. Hay, D. A. et al. Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains. J. Am. Chem. Soc. 136, 9308-9319 (2014).
24. Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20, 306-319 (2014).
25. Henry, R. A., Kuo, Y. M. & Andrews, A. J. Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4. Biochemistry 52, 5746-5759 (2013).
26. Xu, Y. M., Du, J. Y. & Lau, A. T. Posttranslational modifications of human histone H3: an update. Proteomics 14, 2047-2060 (2014).
27. Saharinen, P., Tammela, T., Karkkainen, M. J. & Alitalo, K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 25, 387-395 (2004).
28. Detry, B. et al. Sunitinib inhibits inflammatory corneal lymphangiogenesis. Invest. Ophthalmol. Vis. Sci. 54, 3082-3093 (2013).
29. Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076-1080 (2009).
30. Stacker, S. A. et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat. Rev. Cancer 14, 159-172 (2014).
31. Bazigou, E. et al. Integrin-a 9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev. Cell 17, 175-186 (2009).
32. Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756 (1973).
33. Kriehuber, E. et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194, 797-808 (2001).
34. Michieli, P. et al. Targeting the tumor and its microenvironment by a dual-function decoy Met receptor. Cancer Cell 6, 61-73 (2004).
35. Carlotti, F. et al. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Mol. Ther. 9, 209-217 (2004).
36. Korff, T., Krauss, T. & Augustin, H. G. Three-dimensional spheroidal culture of cytotrophoblast cells mimics the phenotype and differentiation of cytotrophoblasts from normal and preeclamptic pregnancies. Exp. Cell. Res. 297, 415-423 (2004).
37. Blacher, S., Detry, B., Bruyere, F., Foidart, J. M. & Noel, A. Additional parameters for the morphometry of angiogenesis and lymphangiogenesis in corneal flat mounts. Exp. Eye Res. 89, 274-276 (2009).
38. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
39. Xu, H. et al. A signal-noise model for significance analysis of ChIP-seq with negative control. Bioinformatics 26, 1199-1204 (2010).
40. Robinson, M.D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
41. Basu, S. S. & Blair, I. A. SILEC: a protocol for generating and using isotopically labeled coenzyme A mass spectrometry standards. Nat. Protocols 7, 1-12 (2011).
42. Culic, O., Gruwel, M. L. & Schrader, J. Energy turnover of vascular endothelial cells. Am. J. Physiol. 273, C205-C213 (1997).
43. Ataullakhanov, F. I. & Vitvitsky, V. M. What determines the intracellular ATP concentration. Biosci. Rep. 22, 501-511 (2002).
44. Huang, H. et al. Physiological levels of ATP negatively regulate proteasome function. Cell Res. 20, 1372-1385 (2010).
45. Atkinson, D. E. & Walton, G. M. Adenosine triphosphate conservation in metabolic regulation. Rat liver citrate cleavage enzyme. J. Biol. Chem. 242, 3239-3241 (1967).
46. Aragones, J. et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40, 170-180 2008).
47. McCloy, R. A. et al. Partial inhibition of Cdk1 in G2 phase overrides the SAC and decouples mitotic events. Cell Cycle 13, 1400-1412 (2014).